* This field is required

Chickenpox

Solutions
Online Inquiry

Chickenpox

The development of precise and efficient diagnostic tools is crucial for the successful supervision and containment of chickenpox. At our company, we are dedicated to the development of state-of-the-art in vitro diagnostic (IVD) reagents/kits and the design of bolstering diagnostic devices to tackle the complexities inherent in chickenpox diagnosis.

Introduction to Chickenpox

Chickenpox, medically termed varicella-zoster, results from an infection caused by the varicella-zoster virus. It typically manifests as an itchy, blister-like skin rash and is highly contagious. The disease is primarily spread through bodily fluids and close bodily contact. Chickenpox can impact individuals across all age groups, although it is more prevalent among children. Over recent years, the prevalence of chickenpox has notably declined owing to advancements in vaccine development.

The life cycle of the varicella-zoster virus.Fig. 1 Schematic diagram of the life cycle of the varicella-zoster virus (VZV). (Ishihara, Ryuhei, et al., 2024)

Diagnostic Biomarkers for Chickenpox

Early diagnosis facilitates the identification and prompt therapeutics of chickenpox. Diagnostic biomarkers are measurable indicators that can be detected in various biological samples, providing valuable information about the presence, severity or progression of the disease.

Antigens

Antigens are molecules that can induce an immune response in the body. Detection of varicella-zoster virus (VZV) antigens in skin lesions or blood samples indicates that the virus is actively replicating. Common VZV antigens used for diagnostic purposes include glycoproteins and viral capsid proteins.

Antibodies

Antibodies are proteins produced by the immune system. Testing for VZV-specific antibodies, including IgM and IgG, can provide insights into an individual's immune status. Elevated levels of IgM antibodies may indicate recent primary infection, while IgG antibodies suggest past exposure to the virus.

DNA

Polymerase chain reaction (PCR) assays are commonly used to amplify and detect VZV DNA in samples with high sensitivity and specificity. The presence of VZV DNA in blood or lesion samples can confirm the diagnosis of chickenpox and differentiate it from other rash-causing conditions.

IVD Kits for Chickenpox

In vitro diagnostic (IVD) kits detect specific biomarkers associated with the varicella-zoster virus (VZV), offering a rapid and reliable diagnostic method for chickenpox. This rapid diagnosis enables healthcare providers to promptly initiate appropriate therapeutics, reduce the risk of complications, and implement infection control measures.

Kits Applications Detection Methods
Varicella-Zoster Virus (VZV) Gene Detection Kit Qualitative detection of varicella-zoster virus (VZV) DNA. PCR
Varicella-Zoster Virus (VZV) Antibody Test Kit Testing for varicella-zoster virus specific antibodies, such as IgA, IgG, and IgM. ELISA
Varicella-Zoster Virus (VZV) Antigen Detection Kit Qualitative detection of VZV antigens in samples, such as glycoproteins or viral capsid proteins. Immunofluorescence Assay (IFA)

Our Services

Our company specializes in offering advanced IVD solutions for infectious diseases like chickenpox, dedicated to creating customized antigen, antibody, and DNA detection kits to enhance early detection and efficient management of chickenpox. These kits are utilized alongside supplementary diagnostic devices to optimize detection sensitivity and specificity.

Our offerings extend beyond this scope. In order to expedite prompt diagnosis and personalized therapeutics for chickenpox, we offer point-of-care testing (POCT) and companion diagnostic development services. These services are instrumental in enhancing the efficacy and precision of chickenpox diagnosis, empowering individuals affected by the condition to embrace tailored care strategies.

If you are interested in our services, please feel free to contact us for more details and quotation information of related services.

Reference

  1. Ishihara, Ryuhei, et al. "Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine." Biomolecules 14.7 (2024): 739.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.